Transforming growth factor-β mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons

European Journal of Neuroscience

Volumn 10, Issue 8, 1998, Pages 2746-2750

  Krieglstein, Kerstin ^a,c   Reuss, Bernhard ^a   Maysinger, Dusica ^a,b   Unsicker, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MCGILL UNIVERSITY   (Canada)

^c Department of Anatomy and Cell Biology III ^*  (Germany)

Author keywords

Cell culture; Embryonic rat mesencephalon; Neuron survival; Synergisms of neurotrophic factors; Tyrosine hydroxylase

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; NEUROTROPHIC FACTOR; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TYROSINE 3 MONOOXYGENASE; ANTIBODY; DOPAMINE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO CELL; GENE INDUCTION; LUNG ALVEOLUS EPITHELIUM; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; CELL CULTURE; CELL DIVISION; CORPUS STRIATUM; CULTURE MEDIUM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; NERVE CELL; TIME; WISTAR RAT;

ANIMALS; ANTIBODIES; ASTROCYTES; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CORPUS STRIATUM; CULTURE MEDIA, CONDITIONED; DOPAMINE; EMBRYO; FIBROBLAST GROWTH FACTOR 2; MESENCEPHALON; NEURONS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031903468     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00324.x     Document Type: Article

References (29)

1. Abe, M., Harpel, J.G., Metz, C.N., Nunes, I., Loskutoff, D.I. & Rifkin, D.B. (1994) An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promotor-luciferase construct. Anal. Biochem., 216, 276-284.
2. Agid, Y. (1991) Parkinson's disease: pathophysiology. Lancet, 337, 1321-1327.
3. Bean, A.J., Eide, R., Cao, Y., Oellig, C., Tammanga, C., Goldstein, M., Petersson, R.F. & Hökfelt, T. (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc. Natl. Acad. Sci. USA, 88, 10237-10241.
4. Beck, K.D. (1994) Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol., 44, 497-451.
5. Bieger, S. & Unsicker, K. (1997) Functions of fibroblast growth factors (FGFs) in the nervous system. In Bell C. (ed.), Chemical Factors in Neural Growth, Degeneration and Repair. Elsevier, Amsterdam, pp. 339-375.
6. Ehrhard, P.E., Ganter, U., Bauer, J. & Otten, U. (1993) Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA, 90, 5423-5427.
7. Engele, J. & Bohn, M.C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci., 11, 3070-3078.
8. Ferrari, G., Minozzi, M.-C., Toffano, G., Léon, A. & Skaper, A.D. (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Devl. Biol., 133, 140-147.
9. Flanders, K.C., Lüdecke, G., Engels, S., Cissel, D.S., Roberts, A.B., Kondaiah, P., Lafyatis, R., Sporn, M.B. & Unsicker, K. (1991) Immunhistochemical localization of transforming growth factor-βs in the nervous system of the mouse embryo. Development, 113, 183-191.
10. Flanders, K.C., Lüdecke, G., Renzig, J., Hamm, C., Cissel, D.S. & Unsicker, K. (1993) Effect of TGF-βs and bFGF on astroglial cell growth and gene expression in vitro. Mol. Cell Neurosci., 4, 406-417.
11. Gaul, G. & Lübbert, H. (1992) Cortical astrocytes activated by basic fibroblast growth factor secrete molecules that stimulate differentiation of mesencephalic neurons. Proc. R. Soc. Lond. B, 249, 57-63.
12. Hou, J.-G.G. & Mytilineou, C. (1996) Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopaminergic neurons in vitro. Brain Res., 724, 145-148.
13. Kiefer, R., Streit, W.J., Toyka, K.V., Kreutzberg, G.W. & Hartung, H.-P. (1995) Transforming growth factor-β1: a lesion-associated cytokine of the nervous system. Int. J. Devl. Neurosci., 13, 331-339.
14. Krieglstein, K., Rufer, M.. Suter-Crazzolara, C. & Unsicker, K. (1995a) Neural functions of the transforming growth factor β. Int. J. Dev. Neurosci., 13, 301-315.
15. Krieglstein, K., Suter-Crazzolara, C., Fischer, W.H. & Unsicker, K. (1995b) TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J., 14, 736-742.
16. Krieglstein, K. & Unsicker, K. (1995) Bovine chromaffin granules contain and release a transforming growth factor-β-like activity. J. Neurochem., 65, 1423-1426.
17. Krieglstein, K. & Unsicker, K. (1996) Distinct modulatory actions of TGF-β and LIF on neurotrophin-mediated survival of developing sensory neurons. Neurochem. Res., 21, 849-856.
18. O'Malley, E.K., Sieber, B.-A., Monison, R.S., Black, I.E. & Dreyfus, C.F. (1994) Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor. Brain Res., 647, 83-90.
19. Otto, D. (1991) Wirkungen des basischen Fibroblastenwachstumsfactors (bFGF) auf neurotoxingeschädigte Neurone des nigrostriatalen Systems von Maus und Ratte. Marburg/Lahn, Philipps-Universität.
20. Otto, D. & Unsicker, K. (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci., 10, 1912-1921.
21. Otto, D. & Unsicker, K. (1994) FGF-2 in the MPTP-model of Parkinson's disease. Effects on astroglial cells. Glia, 11, 47-56.
22. Reuss, B., Dermitzel, R. & Unsicker, K. (1998) Fibroblast growth factor 2 (FGF-2) differentially regulates connexin (cx) 43 expression and function in astroglial cells from distinct brain regions. Glia, 22, 19-30.
23. Roberts, A.B. & Sporn, M.B. (1990). The transforming growth factors-βs. In Sporn, M. B. and Roberts, A. B. (eds) Handbook of Experimental Pharmacology, Vol. 95. Springer, Heidelberg, pp. 419-472.
24. Rufer, M., Wirth, S.B., Hofer, A., Dermitzel, R., Pastor, A., Kettenmann, H. & Unsicker, K. (1996) Regulation of Connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-Iesioned, FGF-2-tretaed Parkinsonian mice. J. Neurosci. Res., 46, 606-617.
25. Tooyama, I., Kawamata, T., Walker, D., Yamada, T., Hanai, K., Kimura, K., Iwane, M., Igarashi, K., McGeer, E.G. & McGeer, P.L. (1993) Loss of basic fibroblast growth factors in substantia nigra neurons in Parkinson's disease. Neurology, 43, 372-376.
26. Unsicker, K., Reichert-Preibsch, H., Schmidt, R., Pettmann, B., Labourdette, G. & Sensenbrenner, M. (1987) Astroblast and fibroblast growth factors have neurotrophic functions for peripheral and central nervous system neurons. Proc. Natl. Acad. Sci. USA, 84, 5459-5463.
27. Unsicker, K., Reichert-Preibsch, H. & Wewetzer, K. (1992) Stimulation of neuron survival by basic FGF and CNTF is a direct effect and not mediated by non-neuronal cells: evidence from single cell cultures. Dev. Brain Res., 65, 285-288.
28. Unsicker, K., Suter-Crazzolara, C. & Krieglstein, K. (1996) Functions of growth facgtors in the development and maintenance of midbrain dopaminergic neurons: Concepts, facts, and prospects of the transforming growth factors β. In: Growth Factors as Drugs for Neurological and Sensory Disorders. (CIBA Foundation Symposium #196) Wiley, Chichester, UK, pp. 70-84.
29. Wirth, S.B., Rufer, M. & Unsicker, K. (1996) Early effects of FGF-2 on glial cells in the MPTP-lesioned striatum. Exp. Neurol., 137, 191-200.